Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $622.78 million. The enterprise value is $234.75 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TRDA has 35.41 million shares outstanding. The number of shares has increased by 9.14% in one year.
| Current Share Class | 35.41M |
| Shares Outstanding | 35.41M |
| Shares Change (YoY) | +9.14% |
| Shares Change (QoQ) | +14.43% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 51.71% |
| Float | 18.51M |
Valuation Ratios
The trailing PE ratio is 11.34.
| PE Ratio | 11.34 |
| Forward PE | n/a |
| PS Ratio | 2.90 |
| Forward PS | 12.10 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 4.27 |
| EV / Sales | 1.09 |
| EV / EBITDA | 3.83 |
| EV / EBIT | 4.06 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.59, with a Debt / Equity ratio of 0.15.
| Current Ratio | 6.59 |
| Quick Ratio | 6.42 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.43% and return on invested capital (ROIC) is 9.03%.
| Return on Equity (ROE) | 16.43% |
| Return on Assets (ROA) | 6.95% |
| Return on Capital (ROIC) | 9.03% |
| Revenue Per Employee | $1.35M |
| Profits Per Employee | $345,604 |
| Employee Count | 159 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $21.47 million in taxes.
| Income Tax | 21.47M |
| Effective Tax Rate | 28.09% |
Stock Price Statistics
The stock price has increased by +22.84% in the last 52 weeks. The beta is -0.18, so TRDA's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | +22.84% |
| 50-Day Moving Average | 18.48 |
| 200-Day Moving Average | 15.77 |
| Relative Strength Index (RSI) | 41.90 |
| Average Volume (20 Days) | 128,909 |
Short Selling Information
The latest short interest is 1.53 million, so 4.31% of the outstanding shares have been sold short.
| Short Interest | 1.53M |
| Short Previous Month | 1.61M |
| Short % of Shares Out | 4.31% |
| Short % of Float | 8.25% |
| Short Ratio (days to cover) | 11.43 |
Income Statement
In the last 12 months, TRDA had revenue of $215.23 million and earned $54.95 million in profits. Earnings per share was $1.55.
| Revenue | 215.23M |
| Gross Profit | 95.04M |
| Operating Income | 57.78M |
| Pretax Income | 40.51M |
| Net Income | 54.95M |
| EBITDA | 61.30M |
| EBIT | 57.78M |
| Earnings Per Share (EPS) | $1.55 |
Full Income StatementBalance Sheet
The company has $449.34 million in cash and $61.31 million in debt, giving a net cash position of $388.03 million or $10.96 per share.
| Cash & Cash Equivalents | 449.34M |
| Total Debt | 61.31M |
| Net Cash | 388.03M |
| Net Cash Per Share | $10.96 |
| Equity (Book Value) | 422.45M |
| Book Value Per Share | 11.93 |
| Working Capital | 394.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.97 million and capital expenditures -$3.50 million, giving a free cash flow of -$17.46 million.
| Operating Cash Flow | -13.97M |
| Capital Expenditures | -3.50M |
| Free Cash Flow | -17.46M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
Gross margin is 44.16%, with operating and profit margins of 26.85% and 25.53%.
| Gross Margin | 44.16% |
| Operating Margin | 26.85% |
| Pretax Margin | 35.51% |
| Profit Margin | 25.53% |
| EBITDA Margin | 28.48% |
| EBIT Margin | 26.85% |
| FCF Margin | n/a |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.14% |
| Shareholder Yield | -9.14% |
| Earnings Yield | 8.82% |
| FCF Yield | -2.80% |
Analyst Forecast
The average price target for TRDA is $24.75, which is 40.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.75 |
| Price Target Difference | 40.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | -14.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.5 |
| Piotroski F-Score | 5 |